Advertisement
(Photo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM095)
Dr. Bates combines more than twelve years of surgical practice with solidregenerative medicine industry experience. He has practiced in orthopedic,dermatologic, vascular, oncologic and general surgery, infectious diseases andintensive care, both in the U.S. and Australia. An accomplishedboard-certified plastic and reconstructive surgeon, Dr. Bates will serve animportant and multi-faceted role within Organogenesis. In addition to leadingthe company's clinical study department, Dr. Bates will strengthenOrganogenesis' links to the surgical community. He will also impact patientlives by collaborating with Organogenesis research and development teams toguide new product development from lab science through to approved products.
Advertisement
"This is an exciting time for Organogenesis, and Damien's appointmentserves to solidify our executive team," said Geoff MacKay, chief executiveofficer of Organogenesis. "Damien's wealth of experience in tissueengineering, stem cell biology and surgical wound healing is a great fit forOrganogenesis as we grow our company, as well as our product pipeline."
Organogenesis is in the midst of a large expansion, both in employees aswell as facilities, and also recently acquired the electro-spinning platformtechnology company NanoMatrix. The company is currently developing a number ofnew products, and recently launched the first-ever direct-to-consumer (DTC)educational campaign for a living cell therapy (its flagship productApligraf(R)).
Prior to joining Organogenesis, Dr. Bates served as attending plastic andreconstructive surgeon for the University of Colorado, The Children's andDenver Health hospitals. Most recently, Dr. Bates was with Baxter BioSurgeryas a global associate medical director in regenerative surgery. Dr. Bates islicensed to, and has practiced medicine in, both the U.S. and Australia, withmore than 12 years of clinical experience in surgery, infectious diseases andintensive care.
Dr. Bates' expertise includes a focus in tissue engineering, stem cellbiology and wound healing. He has presented at numerous annual scientificmeetings and medical conferences, including the U.S. Society of DevelopmentalBiology, the Surgical Research Society of Australasia, the Society ofUniversity Surgeons and the 7th International Conference on Limb Development& Regeneration. His research has been published in a variety of journals,including Developmental Biology, the Annals of Plastic Surgery and Plastic& Reconstructive Surgery.
About Regenerative Medicine
A new frontier in healthcare, regenerative medicine is an evolvingtherapeutic approach that utilizes living cells to repair or replace bodytissue damaged by injury, disease or the aging process. It is amultidisciplinary field involving biology, medicine and engineering.
Regenerative therapies rely on the body's own natural ability to repairand regenerate, and enable the body to heal itself Regenerative medicinealso empowers scientists to grow living cells, tissues and organs in thelaboratory, and to safely implant them into the human body for the purposes ofhealing.
The related terms "Tissue Regeneration," "Tissue Engineering" and "StemCell Therapies" are often used to refer to some of the activities under theumbrella of regenerative medicine.
About Organogenesis, Inc.
Massachusetts based Organogenesis, Inc. is the world's most successfulregenerative medicine company and is focused in areas of bio-active woundhealing, bio-surgery and bio-aesthetics. Organogenesis delivers living tissue"on demand," and its mission is to bring the medical marvel of regenerativemed
